These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30774851)

  • 1. Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches.
    Hong R; Li X
    Medchemcomm; 2019 Jan; 10(1):10-25. PubMed ID: 30774851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a Multi-target Model to Predict the Activity of Monoamine Oxidase A and B Drugs.
    Concu R; González-Durruthy M; Cordeiro MNDS
    Curr Top Med Chem; 2020; 20(18):1593-1600. PubMed ID: 32493193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanism and Structure-activity Relationship of the Inhibition Effect between Monoamine Oxidase and Selegiline Analogues.
    Yang C; Wang X; Gao C; Liu Y; Ma Z; Zang J; Wang H; Liu L; Liu Y; Sun H; Wang W
    Curr Comput Aided Drug Des; 2024; 20(5):474-485. PubMed ID: 37138424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.
    Manzoor S; Hoda N
    Eur J Med Chem; 2020 Nov; 206():112787. PubMed ID: 32942081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.
    Chaurasiya ND; Leon F; Muhammad I; Tekwani BL
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors.
    Behl T; Kaur D; Sehgal A; Singh S; Sharma N; Zengin G; Andronie-Cioara FL; Toma MM; Bungau S; Bumbu AG
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update.
    Tripathi RKP; Ayyannan SR
    Med Res Rev; 2019 Sep; 39(5):1603-1706. PubMed ID: 30604512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sizes and ligands tuned gold nanocluster acting as a new type of monoamine oxidase B inhibitor.
    Wu X; Xu H; Luo F; Wang J; Zhao L; Zhou X; Yang Y; Cai H; Sun P; Zhou H
    Biosens Bioelectron; 2021 Oct; 189():113377. PubMed ID: 34090156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the Detailed Structure-Activity Relationships of Isatin and Their Isomers As Monoamine Oxidase Inhibitors.
    Kumar S; Nair AS; Abdelgawad MA; Mathew B
    ACS Omega; 2022 May; 7(19):16244-16259. PubMed ID: 35601305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological therapies.
    Binda C; Milczek EM; Bonivento D; Wang J; Mattevi A; Edmondson DE
    Curr Top Med Chem; 2011 Nov; 11(22):2788-96. PubMed ID: 22039878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine natural products with monoamine oxidase (MAO) inhibitory activity.
    Hong A; Tu LC; Yang I; Lim KM; Nam SJ
    Pharm Biol; 2020 Dec; 58(1):716-720. PubMed ID: 32697127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of early studies of monoamine oxidase to present concepts.
    Kopin IJ
    J Neural Transm Suppl; 2006; (71):79-86. PubMed ID: 17447418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors.
    Kumar S; Bhowmik R; Oh JM; Abdelgawad MA; Ghoneim MM; Al-Serwi RH; Kim H; Mathew B
    Sci Rep; 2024 Feb; 14(1):4868. PubMed ID: 38418571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI; Herrmann N; Walker SE
    CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of MAO inhibitors: safety and future.
    Yamada M; Yasuhara H
    Neurotoxicology; 2004 Jan; 25(1-2):215-21. PubMed ID: 14697896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer's and Parkinson's Disease.
    Özdemir Z; Alagöz MA; Bahçecioğlu ÖF; Gök S
    Curr Med Chem; 2021; 28(29):6045-6065. PubMed ID: 33538661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of estrogen on monoamine oxidase activity.
    Chakravorty SG; Halbreich U
    Psychopharmacol Bull; 1997; 33(2):229-33. PubMed ID: 9230635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of [3H]quinpirole binding at striatal D2 dopamine receptors by a monoamine oxidaseA-like site: evidence from radioligand binding studies and D2 receptor- and MAO(A)-deficient mice.
    Levant B; Morgan KA; Ahlgren-Beckendorf JA; Grandy DK; Chen K; Shih JC; Seif I
    Life Sci; 2001 Nov; 70(2):229-41. PubMed ID: 11787947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors.
    Ramesh M; Dokurugu YM; Thompson MD; Soliman ME
    Comb Chem High Throughput Screen; 2017; 20(6):492-509. PubMed ID: 28294055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.